Malaria-like symptoms associated with a natural Plasmodium reichenowi infection in a chimpanzee
- Anaïs Herbert1Email author,
- Larson Boundenga2, 5,
- Anne Meyer3,
- Diamella Nancy Moukodoum2,
- Alain Prince Okouga2,
- Céline Arnathau4,
- Patrick Durand4,
- Julie Magnus2,
- Barthélémy Ngoubangoye1,
- Eric Willaume3,
- Cheikh Tidiane Ba5,
- Virginie Rougeron2, 4,
- François Renaud4,
- Benjamin Ollomo2Email author and
- Franck Prugnolle2, 4Email author
© Herbert et al. 2015
Received: 18 February 2015
Accepted: 20 May 2015
Published: 28 May 2015
Although Plasmodium infections have never been clearly associated with symptoms in non-human primates, the question of the pathogenicity of Plasmodium parasites in non-human primates still remains unanswered. A young chimpanzee, followed before and after release to a sanctuary, in a semi-free ranging enclosure located in an equatorial forest, showed fever and strong anaemia associated with a high Plasmodium reichenowi infection, shortly after release. The animal recovered from anaemia after several months despite recurrent infection with other Plasmodium species. This may be the first description of malaria-like symptoms in a chimpanzee infected with Plasmodium.
KeywordsPlasmodium Pan troglodytes Chimpanzee Symptom Malaria Anaemia Hyperthermia Fever
Despite their genetic proximity with human parasite species especially P. falciparum, it is still unclear whether ape Plasmodium are virulent, that is whether great apes express disease or not when they are infected . A case of a fatal Plasmodium infection in a chimpanzee was previously described , as well as in a gorilla , but the exact nature of the parasite involved was never determined with molecular tools, thus leaving the possibility of an infection with a human parasite (P. falciparum in particular). In addition, other pathogens could have caused these deaths and no special efforts were made to reject these possibilities. In contrast, other authors showed that the presence of Plasmodium in African great apes was not correlated with any increase of temperature or any other symptoms  or that the haematologic and biochemical values, as well as the majority of immunologic parameters, remained unaltered in chimpanzees infected with P. falciparum .
Some researchers noticed malaria-like symptoms responding to anti-malaria treatment in orangutans but without clear evidence of the presence of the pathogen . In non-human primates other than great apes, studies showed that experimental infections of rhesus macaques with Plasmodium knowlesi, Plasmodium coatneyi, and less often Plasmodium cynomolgi, may be characterized by jaundice, anorexia, listlessness, fever, anaemia, and splenomegaly in spleen-intact animals . Moreover, P. knowlesi-infected baboons expressed either acute infection with multiple system organ dysfunctions and cerebral involvement, or a chronic infection with spleen enlargement .
Therefore, no evidence of symptoms was ever clearly associated with natural Plasmodium infection in non-human primates, especially in great apes. This case present what could be the first description of symptoms associated to a clearly identified natural Plasmodium infection in a chimpanzee.
A 6-year-old female chimpanzee (Pan troglodytes troglodytes), named Wonga, was brought to the Centre International de Recherches Médicales de Franceville (CIRMF) after being confiscated from illegal owners in Libreville, Gabon. She was captured by the owners after they killed her mother and was kept as a pet for most of her life, living inside the owners’ house in an urban environment. She spent her quarantine at CIRMF and cleared out after 90 days. She was then transferred to the sanctuary “Parc de la Lékédi”, Bakoumba (Haut-Ogooué, Gabon).
The sanctuary “Parc de la Lékédi”, Bakoumba, holds various primates species, including gorillas, chimpanzees and small monkeys, all bushmeat-poaching-issued orphans, which have been confiscated by the Gabonese Government, gone through a quarantine period at the Centre International de Recherches Médicales de Franceville (CIRMF) and finally released into semi-free ranging enclosures in the sanctuary. Wonga was released into a group of 10 chimpanzees, ranging from 3 to 12 year-old, sharing a 7-ha-semi-free ranging enclosure in dense equatorial forest. The chimpanzees are left in the enclosure nights and days, and sleep in the trees. Food supplementation is offered every day, around 10 am and 2 pm, and consists of fruits and protein cakes. During feeding, keepers monitor animals’ global health on site. Contacts with humans are extremely limited, to annual medical check-ups or health-care-needed anesthesia. Chimpanzees are not followed during the day and evolve freely into the enclosure.
Three and a half months after Wonga’s release into the group, routine medical annual check-up was performed on all the chimpanzees of the group.
All procedures in this study involving animals were approved by the Government of the Republic of Gabon. This study complied with the relevant national guidelines and with the IUCN Policy Statement on Research Involving Species at Risk of Extinction.
The chimpanzee Wonga
Blood count results
Wonga serum chemistry results
Wonga hematological results
During her first post-release check-up (day 192), correlated with her fever, her haematological results showed anaemia, with low haematocrit, low haemoglobin level and low red blood cell count (Table 2 and Fig. 2).
Plasmodium infection detection
Along with blood counts, Wonga was tested for Plasmodium infections during quarantine and after release using two distinct diagnostic tests (thick blood smears and cytochrome b PCR/sequencing) . The three samples tested during quarantine showed no Plasmodium infection (Fig. 2e).
During quarantine and for the three samples, the chimpanzee was screened for several pathogens. Simian Immunodeficiency Virus (SIV, peptides set), Simian T-Cell Leukaemia Virus (STLV, peptides set), hepatitis B (HBV, serology), hepatitis C (HCV, serology), filariosis (leucoconcentration), bacterial infections (bacterial cultures performed on nasal and anal swabs), tuberculosis (intradermal palpebral test) and gastro-intestinal parasites (Bailenger and flotation techniques) were all tested negative. Nevertheless, anti gastrointestinal parasites drugs were preventively administered.
On day 192, filariosis (leucoconcentration), bacterial infections (bacterial cultures performed on nasal and anal swabs), gastro-intestinal parasites (Bailenger and flotation techniques) and tuberculosis (intradermal palpebral test) were checked negative. Because the other chimpanzees of the group are non-infected with SIV, STLV, HBV and HCV and because animals do not have any contacts with wild chimpanzees, these pathogens were not checked on Wonga on day 192.
Comparison to other chimpanzees
Three other chimpanzees, two juvenile females (5 and 6 years old) and one adolescent male (9 years old), were sampled on day 192. Their haemoglobin levels (HB), haematocrit (Ht), and red blood cell counts (RBC) were within or slightly lower than chimpanzees’ normal haematological ranges (for juvenile females: HB = 11.2–15 g/dl; Ht = 34.5–45.9 %; RBC = 4.0–5.9 × 106/mm3; for adolescent males: HB = 12.4–16.4 g/dl; Ht = 37.9–49.7 %; RBC = 4.5–6.1 × 106/mm3) . They did not show either anaemia or hyperthermia, unlike Wonga (Fig. 3).
All chimpanzees of the group were infected with Plasmodium (two of them with P. reichenowi and one with P. malariae), but with a much lower parasitaemia than Wonga (2720, 4048 and 5130 parasites/μl) (Fig. 3d).
On days 307 and 344, her haematological results still showed strong anaemia (Fig. 5). RBC count was back within normal range, but Hb level, Ht, mean cell volume (MCV) and mean cell haemoglobin (MCH) were low, signing a chronic microcytic and hypochromic anaemia. On day 393, Wonga’s laboratory results showed that she recovered from her anaemia, with much higher Ht, Hb level, MCV and MCH (Fig. 5).
Follow-up on Wonga’s weight was also performed (Fig. 5g); after her release to the sanctuary, she was barely maintaining her weight until day 344. Then, between day 344 and day 393, as she recovered from her anaemia, she spectacularly gained weight in a short period of time.
On day 307, she was tested negative for gastrointestinal infections; however, anti gastrointestinal parasite drug was preventively administered on that day. On days 344 and 393, she was again tested negative for gastrointestinal parasites infections.
Some weeks after her release in a dense tropical forest, Wonga, a 6-year-old female chimpanzee, presented a fever associated with anaemia, characterized by a very low Ht, very low Hb level and a low RBC count, as well as no weight gain since her quarantine. These clinical and laboratory findings were associated with a Plasmodium infection at high parasitaemia. All her symptoms (especially high parasitaemia and strong anaemia) are characteristics of a strong malaria attack in a naïve individual. Indeed, Wonga was kept for most of her life inside a house in an urban environment and may never have been confronted to a Plasmodium infection. Moreover, Wonga was not infected during quarantine, which lasted 3 months. Plasmodium-acquired immunity is believed not to last for a long period of time , thus Wonga may be considered naïve regarding Plasmodium infection. Given her history, the symptoms Wonga expressed may thus be due to the reaction of a naïve animal experiencing its first Plasmodium infection. On the opposite, the other chimpanzees sampled, which have been followed for the past 2 years and have constantly been tested positive for Plasmodium, are definitively not naïve regarding Plasmodium infection. On day 192, Wonga expressed two features that are seen in humans experiencing their first Plasmodium infection: high parasitaemia and severe disease, including severe anaemia. Malaria-naïve patients have significantly higher risk to develop a peak parasitaemia compared to patients born and resident in malaria-endemic countries of Africa . Wonga, a malaria-naïve chimpanzee, did express a peak parasitaemia compared to other chimpanzees resident in the malaria-endemic sanctuary. High levels of parasitaemia can result in substantial destruction of red blood cells, causing a severe anaemia, particularly in non-immune individuals . However, even if Plasmodium-induced haemolysis contributes to a reduction in haemoglobin levels, low haemoglobin levels in anaemic children may also be explained by ineffective erythropoiesis . Studies demonstrated that patients experiencing acute falciparum malaria show bone marrow damage, ineffective erythropoiesis and a reduced rate of erythropoietic proliferation . Therefore, high parasitaemia and ineffective erythropoiesis may explain Wonga’s anaemia. Severe anaemia is also a feature more often expressed by non-immune individuals infected with Plasmodium; it has been shown that non-immune tourists going to Plasmodium-endemic areas are at greater risk to develop severe disease than semi-immune residents, who seem at lower risk for severe disease . This is also true for children experiencing their first malaria infection: severe disease with rapid progression to death occurs in young children without acquired immunity . Most of the mortality associated with P. falciparum infection occurs in immune-naïve African children under 5 years of age. Symptoms of severe P. falciparum malaria include hyperparasitaemia and severe malarial anaemia . Therefore, Wonga’s non-acquired immunity to Plasmodium may explain the hyperthermia and anaemia she experienced, while semi-immune chimpanzees, living in the area for years, did not show any symptoms. Unfortunately, no other Plasmodium-naïve chimpanzees recently introduced in the area was anaesthetized soon after release, thus allowing the same study as Wonga’s. Anaesthesia and sampling are necessary to detect anaemia and hyperthermia, which may explain why malaria-like symptoms were never detected on the other chimpanzees previously released. Given the unique aspect of the case observed, further case studies will thus be necessary to assess whether treatment should be administered.
No difference on alimentation, stress or weather could have biased these results. All individuals compared in this study were sampled the same day, with the same technique and conditions, and live in the same enclosure. None of them suffered malnutrition and all presented a good body condition. No difference in capture, anaesthesia or amount of stress could have been the origin of such a raise in temperature. Wonga was also tested for other diseases which could have been responsible for the fever (for example, bacterial infections), and for the anaemia (for instance, gastrointestinal parasites such as Ancylostoma sp.).
Evolution of the case
After several months (day 307), P. reichenowi had disappeared from Wonga’s blood, but another malaria infection with P. gaboni was observed, associated to a lower parasitaemia. On days 307 and 344, Wonga did not show any hyperthermia but still had microcytic and hypochromic anaemia. During the same period, she did not gain any weight, confirming that her global health was still not optimum. Gastrointestinal parasites infections which could be responsible for these symptoms were again ruled out.
The clearance of P. reichenowi from Wonga could have been due to the development of an immunity of the chimpanzee against this parasite species. The existence of such immunity against chimpanzee parasite was recently indirectly evidenced in natural ape populations by showing that prevalence of infection was lower in older individuals . Regarding P. gaboni, infection was acquired by Wonga any time between day 192 and day 307. Whether this infection induced similar symptoms cannot be told. Further studies should be done to determine if all ape Plasmodium species induce similar symptoms or not. It is nevertheless likely that this infection, even at a low parasitaemia, was partly responsible for the maintenance of the anaemia.
Finally, between day 344 and day 393, after several months without any symptoms other than anaemia and no weight gain, the chimpanzee recovered from her haematological condition, recovered usual haemoglobin levels, and resumed gaining weight. Such recovery could be explained by a progressive accommodation of Wonga’s physiology to the recurrent Plasmodium infections , as observed in humans .
Wonga expressed hyperthermia and strong anaemia correlated with a high parasitaemia Plasmodium infection. Other possible causes of the symptoms observed were ruled out. Then, after several months, and despite recurrent infection with other Plasmodium species, the animal gradually recovered from anaemia. Symptoms such as fever and anaemia were consistent with a strong Plasmodium infection, and showed first evidence of malaria-like symptoms in a likely naïve-chimpanzee infected with Plasmodium.
The authors thank the CIRMF, CNRS, IRD as well as Agence Nationale pour la Recherche (ANR JCJC SVSE 7-2012 ORIGIN) which provided financial support to this study. The authors thank COMILOG and SODEPAL for their help in the study. Authors thank the two reviewers for their very constructive comments.
- Krief S, Escalante AA, Pacheco MA, Mugisha L, André C, Halbwax M, et al. On the diversity of malaria parasites in african apes and the origin of Plasmodium falciparum from bonobos. PLoS Pathog. 2010;6:e1000765.PubMed CentralPubMedView ArticleGoogle Scholar
- Prugnolle F, Durand P, Neel C, Ollomo B, Ayala FJ, Arnathau C, et al. African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum. Proc Natl Acad Sci U S A. 2010;107:1458–63.PubMed CentralPubMedView ArticleGoogle Scholar
- Prugnolle F, Durand P, Ollomo B, Duval L, Ariey F, Arnathau C, et al. A fresh look at the origin of Plasmodium falciparum, the most malignant malaria agent. PLoS Pathog. 2011;7:e1001283.PubMed CentralPubMedView ArticleGoogle Scholar
- Rayner JC, Liu W, Peeters M, Sharp PM, Hahn BH. A plethora of Plasmodium species in wild apes: a source of human infection? Trends Parasitol. 2011;27:222–9.PubMed CentralPubMedView ArticleGoogle Scholar
- Prugnolle F, Ayala F, Ollomo B, Arnathau C, Durand P, Renaud F. Plasmodium falciparum is not as lonely as previously considered. Virulence. 2011;2(1):71–6.PubMedView ArticleGoogle Scholar
- Tarello W. A fatal Plasmodium reichenowi infection in a chimpanzee? Rev Med Vet. 2005;156(10):503–5.Google Scholar
- Fossey D. Gorilla in the mist. 1983.Google Scholar
- Taylor DW, Wells RA, Vernes A, Rosenberg YJ, Vogel S, Diggs CL. Parasitologic and immunologic studies of experimental Plasmodium falciparum infection in nonsplenectomized chimpanzees (Pan troglodytes). Am J Trop Med Hyg. 1985;34:36–44.PubMedGoogle Scholar
- Reid MJC. Plasmodium sp infections in ex-captive bornean orangutans (Pongo pygmaeus) housed at the orangutan care center and quarantine. Kalimantan Tengah, Indonesia: Pasir Panjang; 2005.Google Scholar
- Unwin S, Cress D, Colin C, Bailey W, Boardman W. D425 - Pan African sanctuary alliance primate veterinary healthcare manual. 2nd ed. 2009.Google Scholar
- Ozwara H, Langermans JA, Maamun J, Farah IO, Yole DS, Mwenda JM, et al. Experimental infection of the olive baboon (Paplio anubis) with Plasmodium knowlesi: severe disease accompanied by cerebral involvement. Am J Trop Med Hyg. 2003;69:188–94.PubMedGoogle Scholar
- Howell S, Hoffman K, Bartel L, Schwandt M, Morris J, Fritz J. Normal hematologic and serum clinical chemistry values for captive chimpanzees (Pan troglodytes). Comp Med. 2003;53:413–23.PubMedGoogle Scholar
- Ollomo B, Durand P, Prugnolle F, Douzery E, Arnathau C, Nkoghe D, et al. A new malaria agent in African hominids. PLoS Pathog. 2009;5:29.View ArticleGoogle Scholar
- Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13–36.PubMed CentralPubMedView ArticleGoogle Scholar
- Bunn A, Escombe R, Armstrong M, Whitty CJ, Doherty JF. Falciparum malaria in malaria-naive travellers and African visitors. QJM. 2004;97:645–9.PubMedView ArticleGoogle Scholar
- Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, Ong'echa JM. Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci. 2011;7:1427–42.PubMed CentralPubMedView ArticleGoogle Scholar
- Dormer P, Dietrich M, Kern P, Horstmann RD. Ineffective erythropoiesis in acute human P falciparum malaria. Blut. 1983;46:279–88.PubMedView ArticleGoogle Scholar
- Calleri G, Lipani F, Macor A, Belloro S, Riva G, Caramello P. Severe and complicated Falciparum malaria in italian travelers. J Travel Med. 1998;5:39–41.PubMedView ArticleGoogle Scholar
- Malaria in children under five. [http://www.who.int/malaria/areas/high_risk_groups/children/en/]
- De Nys HM, Calvignac-Spencer S, Thiesen U, Boesch C, Wittig RM, Mundry R, et al. Age-related effects on malaria parasite infection in wild chimpanzees. Biol Lett. 2013;9:20121160.PubMed CentralPubMedView ArticleGoogle Scholar
- Verhoef H, West CE, Kraaijenhagen R, Nzyuko SM, King R, Mbandi MM, et al. Malarial anemia leads to adequately increased erythropoiesis in asymptomatic Kenyan children. Blood. 2002;100:3489–94.PubMedView ArticleGoogle Scholar
- Sumbele IUN, Nkuo Akenji T, Samje M, Ndzeize T, Ngwa EM, Titanji VPK. Haematological changes and recovery associated with treated and untreated Plasmodium falciparum infection in children in the Mount Cameroon Region. J Clin Med Res. 2010;2:143–51.Google Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.